Today announced a remedy for exon analysis predicated on SurePrint G3 Exon Microarrays.

Agilent announces solution for exon analysis based on SurePrint G3 Exon Microarrays Agilent Technology Inc . today announced a remedy for exon analysis predicated on SurePrint G3 Exon Microarrays. The answer provides a major expansion of Agilent’s portfolio of gene expression reagents, bioinformatics and microarrays systems. This new system, available in mid-November, enables researchers to examine alternately expressed exons according to recently updated content, providing a worldwide picture of RNA expression.D., Agilent product supervisor, Gene Expression. In December we introduced the reduced Insight Quick Amp labeling package, which requires only 10 nanograms of total RNA.

This is actually the first Agilent laboratory facility where advancement of application solutions, consumer interactions and training may happen in parallel. Originally opened in 2006, the Bangalore center acts Agilent’s customers across India. Customers now have usage of Agilent’s newest high-end items, like the 7700 Series ICP-MS, 7000B GC-QQQ, 6490 QQQ, 6540 QTOF and the Agilent 1290 and 1260 Infinity LC. Additionally, most of Agilent’s core items, including gas chromatographs, liquid chromatographs, electrophoresis and genomics products, and mass spectrometry systems are available for use. Clients and collaborators can use the center to judge how Agilent products perform with their types of samples and applications. The combined facility has an important role not in applications and solutions advancement just, but in consumer education also.